Winnipeg Free Press - PRINT EDITION

Heart health not just a numbers game

  • Print

VANCOUVER -- Have you been told by your health-care professional you have high blood pressure, high cholesterol or Type 2 diabetes and you need to do something to improve your "numbers"? If so, it is likely their recommendations were based on national clinical practice guidelines written by experts in cardiovascular health.

On the face of it, following guidelines seems a very reasonable approach. What could be the problem?

Well, a recent evaluation of cardiovascular patient guidelines reveals only 12 per cent of the recommendations are based on randomized controlled trials (the highest level of evidence). In contrast, 54 per cent of the recommendations are based purely on opinion and consensus.

Here's what we know well: Evidence from the last 30 years provides pretty solid support that lowering what would be considered higher levels of blood pressure (above 160 to 170 mmHg systolic), especially in Type 2 diabetics, reduces cardiovascular events (heart attacks and strokes) to what many, if not most, would consider a clinically important degree.

Statins reduce the chance of cardiovascular events and one can control symptoms and improve outcomes when very high glucose levels are reduced.

But the evidence for reducing the risk of cardiovascular disease is not nearly as impressive or definitive when it comes to aggressively getting numbers below the commonly recommended lower-number thresholds for blood pressure (<140/90 mmHg), diabetes (hemoglobin A1c < 2.0 mmol/L). This is important, because reducing the chance of cardiovascular events is the only reason we aim to change numbers in the first place.

Given this, it is unfortunate how many patients and their families worry and become obsessed with these quite arbitrary breakpoints. A recent British Medical Journal analysis goes so far as to say our idolizing obsession with changing patient numbers is "damaging patient care."

One of the more tricky aspects is how the magnitude of the cardiovascular benefits is typically presented. A news report may, for example, state that a five-year study of a drug has shown it reduces cardiovascular disease by 25 per cent. Sounds convincing, right?

While this number may be technically correct, it's actually misleading.

That's because a typical study may find those patients who go without medication over five years have an eight per cent chance of a cardiovascular event, whereas if they take the medication in question, their chance decreases to six per cent.

Mathematically, it is true six is lower than eight (a 'relative' difference). But the number that matters is actually two per cent (8 minus 6). In other words, two per cent of people obtained a benefit, but 98 per cent of people on the medication received no cardiovascular benefit.

In the case of statins, drugs routinely prescribed to lower cholesterol, evidence shows the absolute difference in cardiovascular events achieved over a five-year period is roughly one to 1.5 per cent in patients who have never had a heart attack or a stroke. Other popular drugs (ezetimibe, niacin, fibrates) that lower cholesterol numbers have not been shown to consistently reduce the chance of cardiovascular events.

Most blood-pressure drugs (but not atenolol or doxazosin), when used in patients with systolic blood pressures around 160 to 170, lead to a difference in cardiovascular events of two to five per cent, and there is a five to eight per cent reduction when a drug called metformin is used in newly diagnosed diabetics.

Interestingly, other drugs used to lower blood glucose in diabetics have either been shown to have less of a benefit, no benefit or have not been studied. And we can't forget the possible side-effects and the costs for medications, which patients must consider. Since the majority of patients will not get a cardiovascular benefit from these medications, any side-effects really become unacceptable.

Medical guidelines are oddly silent on patient preferences. A recent look at five main Canadian cardiovascular guidelines reveals only 99 of the 90,000 words in the documents address patients' values and preferences. So what's a patient to do?

The best available data show stopping smoking, eating in moderation (the Mediterranean diet has the best evidence), and being active are the three most important things to reduce cardiovascular risk (even if these things don't change your numbers).

Patients should ask their doctors, if a medication is recommended, whether that specific drug has been shown in well-designed clinical trials to reduce cardiovascular disease, and if so, by how much (in absolute numbers). Also, always have a discussion about side-effects and costs of any medication.

The bottom line: The goal is reducing the chance of cardiovascular disease, not just lowering numbers.

In the end, a health-care provider should support the patient decision regardless of the path the patient chooses and not make them feel guilty if they don't blindly follow the latest guideline recommendations.


James McCormack is an expert adviser with and professor with the faculty of pharmaceutical sciences at the University of British Columbia in Vancouver.


Republished from the Winnipeg Free Press print edition May 5, 2012 A17

Fact Check

Fact Check

Have you found an error, or know of something we’ve missed in one of our stories?
Please use the form below and let us know.

* Required
  • Please post the headline of the story or the title of the video with the error.

  • Please post exactly what was wrong with the story.

  • Please indicate your source for the correct information.

  • Yes


  • This will only be used to contact you if we have a question about your submission, it will not be used to identify you or be published.

  • Cancel

Having problems with the form?

Contact Us Directly
  • Print

You can comment on most stories on You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.

You can comment on most stories on You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.

Have Your Say

New to commenting? Check out our Frequently Asked Questions.

Have Your Say

Comments are open to Winnipeg Free Press print or e-edition subscribers only. why?

Have Your Say

Comments are open to Winnipeg Free Press Subscribers only. why?

The Winnipeg Free Press does not necessarily endorse any of the views posted. By submitting your comment, you agree to our Terms and Conditions. These terms were revised effective April 16, 2010.


Make text: Larger | Smaller


Winnipeg Free Press 27 cent digital payment system

View more like this

Photo Store Gallery

  • MIKE.DEAL@FREEPRESS.MB.CA 100615 - Tuesday, June 15th, 2010 The Mane Attraction - Lions are back at the Assiniboine Park Zoo. Xerxes a 3-year-old male African Lion rests in the shade of a tree in his new enclosure at the old Giant Panda building.  MIKE DEAL / WINNIPEG FREE PRESS
  • A water lily in full bloom is reflected in the pond at the Leo Mol Sculpture Garden Tuesday afternoon. Standup photo. Sept 11,  2012 (Ruth Bonneville/Winnipeg Free Press)

View More Gallery Photos


What do you think the punishment should be for Dustin Byfuglien's cross-check on New York Rangers forward J. T. Miller?

View Results

View Related Story

Ads by Google